(Q34301397)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11442156%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Propofol and midazolam in the treatment of refractory status epilepticus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11442156%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11442156%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

A Prasad

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11442156%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

B B Worrall

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11442156%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

E H Bertram

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11442156%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 March 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11442156%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11442156%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11442156%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11442156%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

380-386

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11442156%20AND%20SRC:MED&resulttype=core&format=json

Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings.

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

Barbiturate anesthesia in the treatment of status epilepticus: clinical experience with 14 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

Pentobarbital treatment of refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

Determinants of mortality in status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

Refractory status epilepticus in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

Propofol infusions for status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

Propofol infusion for the treatment of status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

Successful use of propofol in status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

Propofol infusion for control of status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

Propofol in the management of refractory status epilepticus: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

The management of status epilepticus with a continuous propofol infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

Propofol for refractory status epilepticus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

Successful treatment of amoxapine-induced refractory status epilepticus with propofol (diprivan)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

Treatment of refractory generalized status epilepticus with continuous infusion of midazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

Generalized convulsive status epilepticus in the adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

Self-sustaining limbic status epilepticus induced by 'continuous' hippocampal stimulation: electrographic and behavioral characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

The pattern of 72-kDa heat shock protein-like immunoreactivity in the rat brain following flurothyl-induced status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X

Distribution of HSP72 induction and neuronal death following limbic seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.27500.X